ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KENNETH SHIBATA MD

Internal Medicine

11,660

$573K

652
487 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

DANIEL YANG MD

Internal Medicine

5,499

$232K

291
263 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $56

JAMES WILSON MD

Internal Medicine

21,058

$1.01M

774
659 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

SEYED HEJAZI MD

Internal Medicine

7,053

$334K

420
283 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

MATTHEW HOLLON MD, MPH

Internal Medicine

652

$25K

36
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $56

WILLIAM STEWART MD

Internal Medicine

5,226

$187K

193
175 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $56

NAVIN NAGARAJ MD

Internal Medicine

3,908

$179K

242
196 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

MARK FARLEY MD

Internal Medicine

3,944

$217K

218
159 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

FRANK COLE MD

Internal Medicine

11,632

$729K

333
272 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $56

RANU CHOUDHARY MD

Internal Medicine

11,942

$671K

365
338 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

BARBARA ATWOOD MD, LLC

Internal Medicine

3,252

$180K

129
105 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

ELIZA SUTTON

Internal Medicine

1,731

$103K

93
67 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

DAN FISHER MD

Internal Medicine

5,749

$315K

287
251 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $56

DAVID MCKINNEY M.D.

Internal Medicine

6,259

$334K

337
268 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

ANYA CONSIGLIO M.D.

Internal Medicine

3,332

$155K

230
209 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

LUBNA KHAN MD

Internal Medicine

12,677

$628K

527
494 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

JULIE RICKING MD

Internal Medicine

4,518

$274K

233
183 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

25%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

YONG SHIN M.D.

Internal Medicine

10,482

$571K

431
353 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

GENEVIEVE PAGALILAUAN

Internal Medicine

1,588

$82.9K

86
68 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

ALBERT FABIANO MD

Internal Medicine

8,272

$402K

317
256 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

MARY BADGER DO

Internal Medicine

7,614

$356K

337
290 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

MICHAEL TEPPER MD

Internal Medicine

4,138

$322K

152
125 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

30%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$78
Average prescription price

Avg: $56

SALONA SHRESTHA MD

Internal Medicine

2,810

$138K

364
289 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

CORIE SANDALL MD

Internal Medicine

10,950

$835K

507
373 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $56

DANIEL WACHENHEIM MD

Internal Medicine

7,698

$340K

619
518 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank